| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $10.2M | -5.4% |
| SG&A Expense | $8.5M | -11.1% |
| Operating Income | -$18.7M | +8.1% |
| Pre-tax Income | -$19.3M | +2.9% |
| Income Tax | $861K | +60.4% |
| Net Income | -$20.2M | +1.2% |
| EPS (Basic) | -$0.61 | +31.5% |
| EPS (Diluted) | -$0.61 | +31.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.8M | +100.6% |
| Current Assets | $22.2M | +91.7% |
| Total Assets | $22.8M | +88.2% |
| Current Liabilities | $3.4M | -14.3% |
| Long-term Debt | $401K | -8.6% |
| Total Liabilities | $4.3M | -11.1% |
| Stockholders' Equity | $18.6M | +152.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.5M | +2.2% |
| Investing Cash Flow | $5.0M | +0.0% |
| Financing Cash Flow | $28.4M | +118.6% |